Anika Therapeutics, Inc. (ANIK) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 137.8M |
| Enterprise Value | 106.56M |
| P/E Ratio | -105.21 |
| PEG Ratio | -0.35 |
| Price/Sales Ratio | 1.48 |
| Price/Book Ratio | 1.33 |
| Enterprise/Revenue | 1.31 |
| Enterprise/EBITDA | 31.6 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.01 |
| Operating Margin | -0.02 |
| Return On Assets | -0.01 |
| Return On Equity | -0.01 |
| Revenue | 112.82M |
| Revenue/Share | 9.22 |
| Gross Profit | 63.81M |
| EBITDA | -3.58M |
| Net Income | -10.88M |
| Diluted EPS | -0.76 |
| Total Cash | 44.96M |
| Total Cash/Share | 3.36 |
| Total Debt | 24.57M |
| Total Debt/Equity | 0.18 |
| Current Ratio | 3.86 |
| Book Value Per Share | 10.28 |
| 52-Week Change | 40.9 |
| 52-Week High | 22.88 |
| 52-Week Low | 9.01 |
| Moving Average 50 Days | 19.33 |
| Moving Average 200 Days | 16.46 |
| Average Volume | 106,885 |
| Shares Outstanding | 13.4M |
| % Held by Institutions | 89.99 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |